The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

Launched by QIANFOSHAN HOSPITAL · Aug 1, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new test kit called the HIV Ag +Ab Assay Kit (Sysmex) to see how well it can detect HIV in people who have certain health conditions, such as cancer or blood diseases. The researchers want to find out if this test can reliably identify HIV antigens (parts of the virus) and antibodies (the body’s response to the virus) without being confused by other factors that could interfere with the results.

To be eligible for this study, participants need to have a clinical diagnosis of either tumor disease or a blood disease, and their blood samples must meet specific requirements for testing. The trial is currently not recruiting participants yet, so there’s no need to worry about immediate involvement. If you or someone you know might be interested in this study once it starts, it could provide valuable information about how well this new test works for people with these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of tumor Disease or blood disease
• • Blood samples must meet the test requirements
• Exclusion Criteria:
• • N/A